Toxoplasma gondii Recombinant Surface Antigen (SAG 1; P 30) and its Applications in Serodiagnosis and Vaccine Development for Toxoplasmosis

Toxoplasma gondii Recombinant Surface Antigen (SAG 1; P 30) and its Applications in Serodiagnosis and Vaccine Development for Toxoplasmosis. Malaysian Journal of Medicine and Health Sciences (MJMHS), 6 (1). pp. 1-18. ISSN 2636-9346 (2010)



Abstract

Toxoplasmosis, caused by an intracellular protozoan parasite, Toxoplasma gondii, is
widespread throughout the world. The disease is of major medical and veterinary importance,
being a cause of congenital disease and abortion in humans and in domestic animals.[1] In
addition, it has gained importance recently due to toxoplasma encephalitis in AIDS patients.[2]
T. gondii was discovered 100 years ago. Its identification was rapidly followed by the
recognition that it was a human pathogen. During the past 100 years, the spectrum of
diseases caused by this ubiquitous pathogen has expanded to include both congenital and
acute infections as well as the recognition of diseases caused by this pathogen in the
immune-compromised host.

Item Type: Article
Keywords: Toxoplasma, Toxoplasma gondii
Taxonomy: By Subject > Medicine > Rehabilitation Medicine
Local Content Hub: Subjects > Medicine
Depositing User: Adi Azri Mohamad (Sg. Buloh)
Date Deposited: 07 Oct 2021 23:27
Last Modified: 07 Oct 2021 23:30
Related URLs:

Actions (login required)

View Item View Item